| Raltegravir with optimized background therapy for resistant HIV-1 infection RT Steigbigel, DA Cooper, PN Kumar, JE Eron, M Schechter, M Markowitz, ... New England Journal of Medicine 359 (4), 339-354, 2008 | 816 | 2008 |
| Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection RB Jones, LC Ndhlovu, JD Barbour, PM Sheth, AR Jha, BR Long, ... Journal of Experimental Medicine 205 (12), 2763-2779, 2008 | 658 | 2008 |
| Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection DA Cooper, RT Steigbigel, JM Gatell, JK Rockstroh, C Katlama, P Yeni, ... New England Journal of Medicine 359 (4), 355-365, 2008 | 545 | 2008 |
| HIV, gender, race, sexual orientation, and sex work: a qualitative study of intersectional stigma experienced by HIV-positive women in Ontario, Canada CH Logie, LL James, W Tharao, MR Loutfy PLoS medicine 8 (11), e1001124, 2011 | 314 | 2011 |
| Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study MR Loutfy, LM Blatt, KA Siminovitch, S Ward, B Wolff, H Lho, DH Pham, ... Jama 290 (24), 3222-3228, 2003 | 235 | 2003 |
| Long-term efficacy and safety of Raltegravir combined with optimized background therapy in treatment-experienced patients with drug-resistant HIV infection: week 96 results of … RT Steigbigel, DA Cooper, H Teppler, JJ Eron, JM Gatell, PN Kumar, ... Clinical Infectious Diseases 50 (4), 605-612, 2010 | 213 | 2010 |
| Serology and eosinophil count in the diagnosis and management of strongyloidiasis in a non-endemic area. MR Loutfy, M Wilson, JS Keystone, KC Kain The American journal of tropical medicine and hygiene 66 (6), 749-752, 2002 | 200 | 2002 |
| Systematic review of HIV transmission between heterosexual serodiscordant couples where the HIV-positive partner is fully suppressed on antiretroviral therapy MR Loutfy, W Wu, M Letchumanan, L Bondy, T Antoniou, S Margolese, ... PloS one 8 (2), e55747, 2013 | 188 | 2013 |
| Distinct transcriptional profiles in ex vivo CD4+ and CD8+ T cells are established early in human immunodeficiency virus type 1 infection and are characterized by a chronic … MD Hyrcza, C Kovacs, M Loutfy, R Halpenny, L Heisler, S Yang, O Wilkins, ... Journal of virology 81 (7), 3477-3486, 2007 | 163 | 2007 |
| Fertility desires and intentions of HIV-positive women of reproductive age in Ontario, Canada: a cross-sectional study MR Loutfy, TA Hart, SS Mohammed, DS Su, ED Ralph, SL Walmsley, ... PloS one 4 (12), e7925, 2009 | 162 | 2009 |
| Possible SARS coronavirus transmission during cardiopulmonary resuscitation MD Christian, M Loutfy, LC McDonald, KF Martinez, M Ofner, T Wong, ... Emerging infectious diseases 10 (2), 287, 2004 | 160 | 2004 |
| Persistent HIV RNA shedding in semen despite effective antiretroviral therapy PM Sheth, C Kovacs, KS Kemal, RB Jones, JM Raboud, R Pilon, ... Aids 23 (15), 2050-2054, 2009 | 155 | 2009 |
| A role for mucosal IL-22 production and Th22 cells in HIV-associated mucosal immunopathogenesis CJ Kim, A Nazli, OL Rojas, D Chege, Z Alidina, S Huibner, S Mujib, ... Mucosal immunology 5 (6), 670, 2012 | 148 | 2012 |
| Severe acute respiratory syndrome MD Christian, SM Poutanen, MR Loutfy, MP Muller, DE Low Clinical infectious diseases 38 (10), 1420-1427, 2004 | 143 | 2004 |
| Associations between HIV-related stigma, racial discrimination, gender discrimination, and depression among HIV-positive African, Caribbean, and Black women in Ontario, Canada C Logie, LL James, W Tharao, M Loutfy AIDS patient care and STDs 27 (2), 114-122, 2013 | 137 | 2013 |
| Sigmoid Th17 populations, the HIV latent reservoir, and microbial translocation in men on long-term antiretroviral therapy D Chege, PM Sheth, T Kain, CJ Kim, C Kovacs, M Loutfy, R Halpenny, ... Aids 25 (6), 741-749, 2011 | 117 | 2011 |
| Incidence of and risk factors for tenofovir‐induced nephrotoxicity: a retrospective cohort study T Antoniou, JM Raboud, S Chirhin, D Yoong, V Govan, K Gough, ... HIV medicine 6 (4), 284-290, 2005 | 114 | 2005 |
| Gender and ethnicity differences in HIV-related stigma experienced by people living with HIV in Ontario, Canada MR Loutfy, CH Logie, Y Zhang, SL Blitz, SL Margolese, WE Tharao, ... PloS one 7 (12), e48168, 2012 | 108 | 2012 |
| Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials JJ Eron, DA Cooper, RT Steigbigel, B Clotet, JM Gatell, PN Kumar, ... The Lancet Infectious Diseases 13 (7), 587-596, 2013 | 107 | 2013 |
| Trimethoprim-sulfamethoxazole–induced hyperkalemia in patients receiving inhibitors of the renin-angiotensin system: a population-based study T Antoniou, T Gomes, DN Juurlink, MR Loutfy, RH Glazier, MM Mamdani Archives of internal medicine 170 (12), 1045-1049, 2010 | 106 | 2010 |
